NEVVI Medicare utilization intelligence
or

← back

Provider profile

STOLZ, SUSAN PA

Physician Assistant · NPI 1598711467 · MADISON, WI

1
Groups
25
Codes · 2024
10,411
Disclosed services

STOLZ, SUSAN is a Physician Assistant in MADISON, WI, a member of 1 medical group, who billed 25 distinct codes to Medicare Part B in 2024.

Groups: DEAN HEALTH SYSTEMS INC (MADISON, WI)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

10,411
disclosed services
25
codes billed to Medicare Part B
Prior year · CY2023 22,384 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
36415 Insertion of needle into vein for collection of blood sample
96375 Injection of additional new drug or substance into vein
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96372 Injection of drug or substance under skin or into muscle
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96417 Administration of additional new drug or substance into vein, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
51720 Instillation of anti-cancer drug into bladder
81002 Urinalysis, manual test
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
83735 Magnesium level
96374 Injection of drug or substance into vein
96361 Infusion into a vein for hydration, each additional hour

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.